Original article
Multicolor fluorescence in situ hybridization and comparative genomic hybridization reveal molecular events in lung adenocarcinomas and squamous cell lung carcinomas

https://doi.org/10.1016/j.biopha.2008.08.010Get rights and content

Abstract

We have used the molecular cytogenetic techniques of multicolor fluorescence in situ hybridization (M-FISH) and comparative genomic hybridization (CGH) to analyze two established lung cancer cell lines (A549, H520), 80 primary lung adenocarcinoma samples and 80 squamous cell lung carcinoma samples in order to identify common chromosomal aberrations. M-FISH revealed numerous complex chromosomal rearrangements. Chromosomes 5, 6, 11, 12, and 17 were most frequently involved in interchromosomal translocations. CGH revealed regions on 1q, 2p, 3q, 5p, 5q, 7p, 8q, 11q, 12q, 14q, 16p, 17p, 19q, 20q, 21q and 22q to be commonly over-represented and regions on 2q, 3p, 4p, 5q, 7q, 8p, 9p, 13q, 14q, and 17p to be under-represented. In lung adenocarcinomas the most common gains were found in 16p13 (50%); while in squamous cell lung carcinomas the common gains were found in 17q21 (45%) and these alterations were observed to be associated with their specific pathological subtype. In conclusion, the present study contributes to the molecular biological characterization in lung adenocarcinomas and squamous cell lung carcinomas and through evaluation of molecular events to the recently emergent focus on novel markers for lung cancer treatment.

Introduction

Lung cancer is responsible for the highest cancer-related morbidity and mortality worldwide [1]. Non-small cell lung cancer (NSCLC) comprises approximately 80% of all lung cancers, among which adenocarcinoma (AdC) and squamous cell carcinoma (SqC) are now the two most common histological subtypes. Cigarette smoking continues to be an important aetiological factor, with a clear implication of involvement in over 95% of male cases [2]. A correlation between the incidence of lung cancer in females and smoking habit has also been observed in recent years [3].

Due to the high incidence and mortality rates, much effort has been drawn towards investigating the cause and course of NSCLC. Although classical cytogenetic studies by banding analysis can provide an overall view of structural and numerical abnormalities, the frequent presence of karyotypic complexity has precluded more accurate interpretation. Conversely, molecular characterization by comparative genomic hybridization (CGH) and allelotyping has shown common over-representations of 1q, 3q, 5p, 8q and 20, and loss of heterozygosity (LOH) on 3p, 8p, 13q and 17p in NSCLC [4], [5], [6]. Despite the reportedly frequent genomic imbalances, the pattern of karyotypic alterations associated with AdC and SqC remains uncertain.

Comparative genomic hybridization (CGH) allows screening of the entire genome in order to identify regions of gain or loss of DNA and map them according to chromosomal location [7]. A major advantage of CGH is that tissue culture and preparation of metaphase spreads are not required as DNA extracted from a tumor specimen is used. Previous CGH studies of NSCLC cell lines and primary tumors have identified chromosomal regions that are commonly over- or under-represented, including gains of 1q, 3q, 5p, 7p and 8q and losses of 3p, 6q, 8p, 9p and 17p [8], [9], [10]. Multicolor fluorescence in situ hybridization (M-FISH) is a karyotyping technique that uses whole chromosome paints (WCP) to label each chromosome with a unique color [11]. Use of this technique facilitates the karyotyping of tumor cells and allows the identification of marker chromosomes and complex chromosomal rearrangements that would previously have been uninterpretable. Additionally, the use of color has opened up the field to non-cytogeneticists. Despite these technological advances, acquisition of suitable metaphase spreads is still a problem and consequently much of the work on solid tumors with M-FISH has been carried out using established cell lines.

We have now conducted a comprehensive molecular cytogenetic characterization of AdC and SqC tumors. By utilizing M-FISH we analysed one established lung adenocarcinoma cell line (A549) and another squamous cell lung carcinoma cell line (H520). Eighty primary lung adenocarcinoma samples and 80 squamous cell lung carcinoma samples are detected by CGH. Our combined M-FISH and CGH analysis shows distinct patterns of genetic aberration in the two specific NSCLC subtypes, which might in turn influence the different pathogenetic pathways adopted by these tumors. It is hoped that the identification of such changes may eventually lead to improvements in diagnosis and identification of prognostic factors for lung adenocarcinomas and squamous cell lung carcinoma.

Section snippets

Primary tumor samples

One hundred and sixty lung cancer samples were collected from patients with histologically confirmed lung AdC (80) and lung SqC (80) at the departments of thoracic surgery at the First Affiliated Hospital of Nanjing Medical University and oncology hospital of Jiangsu province, China, after informed consent was obtained. The clinicopathologic characteristics of the samples are shown in Table 1. The genomic DNA was extracted using the PureGene DNA isolation kit (Qiagen, Hilden, Germany). The

M-FISH

The composite karyotype for each sample analyzed by M-FISH (Fig. 1, Fig. 2) is shown in Table 2. In total, eight different interchromosomal translocations were observed in the composite karyotypes from the two samples and two of these were observed in both AdC cell line (A549) and SqC cell line (H520) samples. They were t(5;11) and t(6;17). Thirteen chromosomes were involved in at least one translocation, but five chromosomes (5, 6, 11, 12 and 17) appeared to be involved particularly

Discussion

The karyotypes of the primary tumor samples were highly complex and contained many structural aberrations, including the involvement of some chromosomes in many different rearrangements within a single karyotype. We have analyzed two established lung cancer cell lines (A549, H520), 80 primary lung adenocarcinoma samples and 80 squamous cell lung carcinoma samples using modern molecular cytogenetic techniques that allow genetic aberrations to be elucidated, which would have been uninterpretable

References (39)

  • B.R. Balsara et al.

    Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p and 8q in human non-small cell lung carcinomas

    Cancer Res

    (1997)
  • A.M. Björkqvist et al.

    DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma

    Genes Chromosomes Cancer

    (1998)
  • M.R. Speicher et al.

    Karyotyping human chromosomes by combinatorial multi-fluor FISH

    Nat Genet

    (1996)
  • J.N.E. Ashman et al.

    Chromosomal alterations in small cell lung cancer revealed by multicolour fluorescent in situ hybridization

    Int J Cancer

    (2002)
  • B. Gunawan et al.

    Site-independent prognostic value of chromosome 9q loss in primary gastrointestinal stromal tumours

    J Pathol

    (2004)
  • B. Gunawan et al.

    Molecular cytogenetic analysis of two primary squamous cell carcinomas of the lung using multicolor fluorescence in situ hybridization

    Virchows Arch

    (2001)
  • D.G. Allen et al.

    Genetic aberrations detected by comparative genomic hybridisation in vulvar cancers

    Br J Cancer

    (2002)
  • K. Umayahara et al.

    Comparative genomic hybridization detects genetic alterations during early stages of cervical cancer progression

    Genes Chromosomes Cancer

    (2002)
  • T. Noguchi et al.

    Chromosomal imbalance in esophageal squamous cell carcinoma: 3q gain correlates with tumor progression but not prognostic significance

    Oncol Rep

    (2003)
  • Cited by (15)

    • Prognostic factors in resected lung carcinomas

      2013, European Journal of Cancer, Supplement
      Citation Excerpt :

      Global chromosomal disarray, often reflected in tumour-cell nuclear pleomorphism, has long been associated with aggressive tumour behaviour. More extensive genetic gains and losses shown by comparative genomic hybridisation (CGH) are associated with higher tumour stage, poor differentiation and tumour progression [110–113], and early relapse of resected adenocarcinoma [114]. Oligonucleotide and cDNA expression microarrays can be used to determine the expression of thousands of genes from mRNA extracted from resected tumour samples [115].

    • SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma

      2011, Journal of Thoracic Oncology
      Citation Excerpt :

      Therefore, an optimized method, i.e., gentle bisulfite chemistry26 and optimized purification protocols to avoid PCR inhibition, might improve sensitivity and specificity of the SHOX2 biomarker. SHOX2 is located on chromosome 3q, a region that has been recognized as one of the most prevalent and significant for chromosomal rearrangements, i.e., genomic gain, in lung cancer.27–29 In a recent publication, amplification of the SHOX2 gene locus was frequently observed in lung cancer samples, and amplification correlated with hypermethylation of the SHOX2 gene.26

    • Prognostic value of chromosomal imbalances in squamous cell carcinoma and adenocarcinoma of the lung

      2011, Annals of Thoracic Surgery
      Citation Excerpt :

      On the other hand, we detected a significant difference of specific chromosomal imbalances between SCC and AC. A lot of genetic aberrations were described to be different in SCC than in AC, but are contradictory for specific chromosomes [8–10, 18, 21]. However, in multiple testing of chromosomes a false discovery rate arise unavoidably and adjustment of the p value reveals a reliable difference of chromosomal aberrations between the 2 tumor types.

    • Association of copy number loss of CDKN2B and PTCH1 with poor overall survival in patients with pulmonary squamous cell carcinoma

      2011, Clinical Lung Cancer
      Citation Excerpt :

      Recent technologic innovations now permit us to refine chromosomal CNAs down to the single-gene level by using high-resolution array-based comparative genomic hybridization (CGH).22 Previous studies have shown that SCC and AC are distinguished by differences in their histopathologic and molecular characteristics, including CNA profiles.23,24 In the present study, we focused on the SCC subtype and aimed to identify gene CNAs with prognostic value for overall survival of SCC patients.

    View all citing articles on Scopus
    View full text